For too long, the promise of personalized therapies has been tantalizingly close, yet frustratingly out of reach for ...

A cut presumably draws blood anywhere in the universe, whether in an Earthly suburb or on some future interstellar voyage yet ...

Aiden Steiner has INAD, a neurodegenerative disease that is often described as a combination of pediatric ALS and Parkinson’s. The 8-year-old is experiencing a rapid decline in his physical and ...

To the casual observer on a photo safari, the giraffe is an iconic, gentle giant browsing the acacia tops. But to a cardiovascular physiologist, a giraffe is a walking, breathing hydraulic paradox.

Henry Ford Health has treated the first Michigan patient outside clinical trials with Roctavian, the newly approved gene therapy for severe hemophilia A.

The patient, who is in his 30s, got the one-time intravenous infusion at the Infusion and Chemotherapy Treatment Center at ...

Australian researchers believe they have finally cracked the mystery of lethal blood clots caused in extremely rare cases by AstraZeneca’s COVID vaccine – and they think new jabs can be designed to ...

High concentrations of lipoprotein(a), a molecule in the body used for accelerating wound healing, blood clotting and stimulating growth of new vessels, are associated with an increased risk of heart ...

This past spring, a biotech company announced the first use of a new gene-editing technology in people to fix an errant gene that causes a severe immune disorder. In June, a baby born with a ...

Research led by Christian Medical College in Vellore, India, has demonstrated the successful use of lentiviral vectors to deliver gene therapy for patients with severe hemophilia A. The study presents ...